These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1420033)
1. Immunogenicity and protective efficacy of solubilized merozoite-enriched Theileria sergenti immunogens. II: Protection against natural exposure under field conditions. Baek BK; Kim BS; Choi IH; Yang KC; Hansen R; Kakoma I Kisaengchunghak Chapchi; 1992 Sep; 30(3):201-8. PubMed ID: 1420033 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of solubilized merozoite-enriched Theileria sergenti immunogens. I: Protection against homologous stabilate challenge. Baek BK; Choi IH; Kim BS; Hansen R; Kakoma I Kisaengchunghak Chapchi; 1992 Jun; 30(2):133-40. PubMed ID: 1627501 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and protective efficacy of solubilized merozoite-enriched Theileria sergenti immunogens. III. Characterization of immunodominant peptides. Baek BK; Kim BS; Rhim BM; Lee HI; Park YH; Kakoma I Korean J Parasitol; 1994 Jun; 32(2):111-6. PubMed ID: 7517694 [TBL] [Abstract][Full Text] [Related]
4. Control of Theileria sergenti infection by vaccination. Onuma M; Kubota S; Kakuda T; Sako Y; Asada M; Kabeya H; Sugimoto C Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):119S-123S. PubMed ID: 9512757 [TBL] [Abstract][Full Text] [Related]
5. Induction of anti-Theileria sergenti antibodies in calves with murine monoclonal anti-idiotype antibody. Tanaka M; Ikeda M; Matsuba T; Okabe T; Takahashi K; Onuma M; Sasaki N J Vet Med Sci; 1991 Oct; 53(5):775-8. PubMed ID: 1836363 [TBL] [Abstract][Full Text] [Related]
6. Vaccine development against Theileria parasite. Onuma M; Kubota S; Kakuda T; Sako Y; Sugimoto C Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():148-54. PubMed ID: 9656367 [TBL] [Abstract][Full Text] [Related]
7. Expression of major piroplasm protein (p33) of Theileria sergenti (Korean isolate) and its immunogenicity in guinea pigs. Kang SW; Kweon CH; Choi EJ; Yoon YD Korean J Parasitol; 1999 Dec; 37(4):277-83. PubMed ID: 10634045 [TBL] [Abstract][Full Text] [Related]
8. Characterization of epitopes on a 32 kDa merozoite surface protein of Theileria sergenti. Zhuang WZ; Kubota S; Sugimoto C; Onuma M Parasite Immunol; 1993 Feb; 15(2):113-9. PubMed ID: 7680447 [TBL] [Abstract][Full Text] [Related]
9. Serological investigation of Theileria sergenti using latex agglutination test in South Korea. Jeong W; Kweon CH; Kim JM; Jang H; Paik SG J Parasitol; 2005 Feb; 91(1):164-9. PubMed ID: 15856893 [TBL] [Abstract][Full Text] [Related]
10. Induction of protective immunity to Theileria annulata using two major merozoite surface antigens presented by different delivery systems. d'Oliveira C; Feenstra A; Vos H; Osterhaus AD; Shiels BR; Cornelissen AW; Jongejan F Vaccine; 1997 Nov; 15(16):1796-804. PubMed ID: 9364686 [TBL] [Abstract][Full Text] [Related]
11. A polymorphism observed in the experimentally successful peptide vaccine sequence derived from Theileria sergenti piroplasm major surface antigen (p33). Kawazu S; Okumura T; Hirogari Y; Miyahara T; Terasaka Y; Hida M; Terada Y; Kamio T; Fujisaki K J Vet Med Sci; 1997 Sep; 59(9):829-31. PubMed ID: 9342711 [TBL] [Abstract][Full Text] [Related]
12. Current status of vaccine development against Theileria parasites. Morrison WI; McKeever DJ Parasitology; 2006; 133 Suppl():S169-87. PubMed ID: 17274845 [TBL] [Abstract][Full Text] [Related]
13. Epitope-Mapping of antigen-specific T lymphocyte in cattle immunized with recombinant major piroplasm surface protein of Theileria sergenti. Kakuda T; Sugimoto C; Onuma M J Vet Med Sci; 2001 Aug; 63(8):895-901. PubMed ID: 11558546 [TBL] [Abstract][Full Text] [Related]
14. Preparation of antibodies directed to the Babesia ovata- or Theileria sergenti-parasitized erythrocytes. Tsuji M; Arai S; Nakamura Y; Kim SJ; Cho SH; He FQ; Ishihara C J Vet Med Sci; 1999 Jan; 61(1):73-6. PubMed ID: 10027170 [TBL] [Abstract][Full Text] [Related]
15. Reciprocal cross-protection induced by sporozoite antigens SPAG-1 from Theileria annulata and p67 from Theileria parva. Hall R; Boulter NR; Brown CG; Wilkie G; Kirvar E; Nene V; Musoke AJ; Glass EJ; Morzaria SP Parasite Immunol; 2000 May; 22(5):223-30. PubMed ID: 10792761 [TBL] [Abstract][Full Text] [Related]
16. Vaccine potential of recombinant antigens of Theileria annulata and Hyalomma anatolicum anatolicum against vector and parasite. Jeyabal L; Kumar B; Ray D; Azahahianambi P; Ghosh S Vet Parasitol; 2012 Sep; 188(3-4):231-8. PubMed ID: 22546546 [TBL] [Abstract][Full Text] [Related]
17. Effect of vaccination in the field with the Theileria annulata (Hisar) cell culture vaccine on young calves born during the winter season. Khatri N; Nichani AK; Sharma RD; Khatri M; Malhotra DV Vet Res Commun; 2001 Apr; 25(3):179-88. PubMed ID: 11334147 [TBL] [Abstract][Full Text] [Related]
18. Prime-boost immunisation against tropical theileriosis with two parasite surface antigens: evidence for protection and antigen synergy. Gharbi M; Darghouth MA; Weir W; Katzer F; Boulter N; Adamson R; Gilbert SC; Jongejan F; Westbroek I; Hall R; Tait A; Shiels B Vaccine; 2011 Sep; 29(38):6620-8. PubMed ID: 21762754 [TBL] [Abstract][Full Text] [Related]
19. Identification of candidate vaccine antigens of bovine hemoparasites Theileria parva and Babesia bovis by use of helper T cell clones. Brown WC; Zhao S; Logan KS; Grab DJ; Rice-Ficht AC Vet Parasitol; 1995 Mar; 57(1-3):189-203. PubMed ID: 7597783 [TBL] [Abstract][Full Text] [Related]
20. Different vaccine strategies used to protect against Theileria annulata. Boulter NR; Brown CG; Kirvar E; Glass E; Campbell J; Morzaria S; Nene V; Musoke A; D'Oliveira C; Gubbels MJ; Jongejan F; Hall FR Ann N Y Acad Sci; 1998 Jun; 849():234-46. PubMed ID: 9668470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]